Anrs, Emerging Infectious Diseases
Clinical trials sponsored by Anrs, Emerging Infectious Diseases, explained in plain language.
-
Scientists test four new HIV vaccine recipes in search of protection
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested four different combinations of experimental HIV vaccines in healthy volunteers at low risk of infection. The study aimed to see which vaccine combinations were safest and best at triggering the immune system to recognize HIV. Researchers enrolled 92 …
Phase: PHASE1, PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test new combo to flush out hidden HIV
Disease control CompletedThis small, early-stage trial tested whether a combination of two existing drugs was safe for people with well-controlled HIV. The goal was to see if these drugs could 'wake up' hidden, dormant virus in the body so the immune system might better control it. Nine men with stable H…
Phase: PHASE1 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Breakthrough trial aims to slash death rates in vulnerable HIV/TB patients
Disease control CompletedThis large Phase 3 trial tested whether a stronger, intensified tuberculosis (TB) treatment regimen could save more lives than standard TB treatment in HIV patients hospitalized with TB and severely weakened immune systems (CD4 ≤ 100 cells/μL). It enrolled 1,330 adults and adoles…
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC